Overview

Intramuscular Ketamine Effect on Postnasal Surgery Agitation

Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
0
Participant gender:
All
Summary
Randomized study of ASA I-II patients, who will undergo elective nasal surgery( septoplasty and septorhinoplasty ) . The patients will be randomly divided into 2 groups: ketamine (group-K) and saline (control group) (group-S). At the time of turning the inhalational agent off , intramuscular racemic ketamine will be administered in a dose of 0.7 mg/kg, whereas group-s will receive intramuscular saline with same volume that would be administered if it was ketamine. Sedation and Agitation scores were recorded using The Richmond agitation-sedation score after extubation.
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Jordanian Royal Medical Services
Treatments:
Ketamine
Criteria
Inclusion Criteria:

1. Age group 18-64 years old

2. ASA I-II

3. BMI 20-29.9

Exclusion Criteria:

1. drug abuse

2. obesity (BMI equal or above 30)

3. patient with diagnosed psychological problems

4. preoperative agitation

5. using sevoflurane to maintain anesthesia.